First case of post-conception Verteporfin exposure: pregnancy and neonatal outcome.

First case of post-conception Verteporfin exposure: pregnancy and neonatal outcome. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

First case of post-conception Verteporfin exposure: pregnancy and neonatal outcome. Abstract Text:

PURPOSE: To assess pregnancy and neonatal outcomes in a woman accidentally exposed to Verteporfin photodynamic therapy in the third week of pregnancy. METHODS: Post-conception counselling and prospective follow-up by telephone interview at Telefono Rosso (Teratology Information Service) were carried out. The baby was examined at birth and at 26 months. RESULTS: The outcome of the pregnancy was normal and a healthy female child with a normal birthweight was born. The baby's follow-up was normal at 26 months. CONCLUSIONS: This is the first reported case of a childbearing woman being accidentally exposed to Verteporfin during pregnancy. No fetal or neonatal adverse effects were documented.

First case of post-conception Verteporfin exposure: pregnancy and neonatal outcome. Publishing Authors By Initials

For similar diagnosis: prognosis: pregnancy outcome research abstracts see: diagnosis: prognosis: pregnancy outcome research

PUBMED ID PMID:

MEDLINE DATE:

First case of post-conception Verteporfin exposure: pregnancy and neonatal outcome. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Acta ophthalmologica Scandinavica

VOLUME: 82

Page Numbers: 623-4

Journal Abbreviation: Acta Ophthalmol Scand

ISSN: 1395-3907

DAY: 17

MONTH: Oct

YEAR: 2004

First case of post-conception Verteporfin exposure: pregnancy and neonatal outcome. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9507578

First case of post-conception Verteporfin exposure: pregnancy and neonatal outcome. Keywords Mesh Terms:

KEYWORDS: Pregnancy Outcome

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: First case of post-conception Verteporfin exposure: pregnancy and neonatal outcome. Information

Substance Name: verteporfin

Registry Number: 129497-78-5

Grant and Affiliation Information for First case of post-conception Verteporfin exposure: pregnancy and neonatal outcome.

AFFILIATION: Telefono Rosso, Teratology Information Service, Department of Obstetrics and Gynaecology, Catholic University of the Sacred Heart, Rome, Italy. marcodesantis@rm.unicatt.it

Country: Denmark

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Acta Ophthalmol Scand

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

First case of post-conception Verteporfin exposure: pregnancy and neonatal outcome Related Publications

• First case of post-conception Verteporfin exposure: pregnancy and neonatal outcome.
• Imatinib interferes with survival of multi drug resistant Kaposi's sarcoma cells.